BIO-CAT Patent 2005

U.S. Patent 6,902,548

U.S. Patent 6,902,548 awarded to BIO-CAT for the extraction and use of a hyaluronidase enzyme from Streptomyces hyalurolyticus to aid in ophthalmic treatments. This bacterial enzyme has higher activity, specificity and purity than comparable animal-derived enzymes. BIO-CAT joins the American Feed Industry Association (AFIA) and Enzyme Technical Association (ETA).